首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Anti-cancer agents in medicinal chemistry

缩写:ANTI-CANCER AGENT ME

ISSN:1871-5206

e-ISSN:1875-5992

IF/分区:2.6/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引3069条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Neha Jain,Lavina Bagoria,Sneha Keelka et al. Neha Jain et al.
Introduction: Therapeutic applications of camel milk in various human ailments have led to the investigation of camel milk against multiple cancers. However, the absence of its scientific evidence in skin cancer protectio...
Kerun Cai,Jiayang Chen,Nuo Li et al. Kerun Cai et al.
Introduction: Chemotherapy-induced gastrointestinal reactions are common in non-small cell lung cancer (NSCLC) patients undergoing carboplatin-based chemotherapy. Jianpi Yiwei granules (JPYW), a traditional Chinese medici...
Rujia Si,Yihan Zhang,Bowen Hu et al. Rujia Si et al.
Introduction: Approximately 30% of patients with diffuse large B-cell lymphoma (DLBCL) develop primary resistance or relapse, owing to the high heterogeneity and aggressive nature of the disease. Consequently, novel drugs...
Maoju Tang,Miyuan Yang,Jiling Wen et al. Maoju Tang et al.
Introduction: Esophageal cancer often develops insidiously, with most cases diagnosed at an advanced stage. Currently, the pathogenesis of esophageal cancer remains unclear, treatment outcomes are poor, and the five-year ...
Qing-Jie Mao,Ya-Quan Zhou,Bing-Shuang Zhao et al. Qing-Jie Mao et al.
Introduction: Laryngeal cancer is a common malignant tumor of the head and neck worldwide. This study aimed to identify potential risk genes, with a particular focus on GPR65, and to investigate its functional mechanism i...
Annoor Awadasseid,Mengda Wu,Feng Zhang et al. Annoor Awadasseid et al.
Introduction: The emergence of immune checkpoint inhibitors has revolutionized the treatment of cancer. Among these, the programmed cell death protein-1 (PD-1)/programmed death-ligand 1 (PD-L1) axis remains a critical tar...
Rachel Cordeiro,Milind Bhitre,Shivam Varma et al. Rachel Cordeiro et al.
Introduction: Pancreatic adenocarcinoma is a highly aggressive cancer with a poor prognosis and a five-year survival rate of just 13%. Its asymptomatic onset, rapid progression, and resistance to therapy make it challengi...
Chenxing Zhang,Bangxue Jiang,Xiaomei Liang et al. Chenxing Zhang et al.
Introduction: Diffuse large B-cell lymphoma (DLBCL) is one of the most prevalent hematological malignancies with high mortality. G1 to S phase transition 1 (GSPT1), a key translation termination factor involved in protein...
Wenxia Chen,Guodong Ding,Yuantang Zhong et al. Wenxia Chen et al.
Introduction: Prostate cancer (PRAD) remains a leading malignancy with limited prognostic biomarkers and therapeutic targets. PRR22, a proline-rich protein-coding gene, has a role in PRAD that remains undefined. This stud...
Jayasheela Sarilla,Vani Mathakala,Uma Maheswari Devi Palempalli Jayasheela Sarilla
Introduction: Recent advancements in nanomedicine have drawn attention to the use of zinc oxide nanoparticles as apoptotic agents to address triple-negative breast cancer. Halophila beccarii-mediated zinc oxide nanopartic...